3D Systems
DDD
3.41
-0.18
-5.01%
3D Systems
US · DDD
#3666 by market cap
Listed 2011
3.41
-0.18
-5.01%
Live - 5344 symbols - heartbeat 225s ago
· 2026-10-08 07:56
Pre-market
3.37
-1.28%
After-hours
3.41
0.00%
Overnight
3.41
0.00%
- Market cap
- 566.56M
- P/E (TTM)i
- -8.53
- P/Bi
- 2.07
- EPSi
- 0.19
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on DDD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -1.70, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -12.09% YoY
Margins
- Gross margin
- 33.87%
- Operating margin
- -24.64%
- Net margin
- 7.72%
Key ratios & quality
- Enterprise valuei
- 574.45M
- Altman Z-Scorei
- -1.70
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 691.55M | 636.35M | 557.24M | 615.64M | 538.03M | 488.07M | 440.12M | 386.90M |
| Gross profit | 324.39M | 280.54M | 223.38M | 263.78M | 214.23M | 196.42M | 164.18M | 131.05M |
| Selling & admin expenses | 272.29M | 254.36M | 219.90M | 227.70M | 244.18M | 210.17M | 210.13M | 161.33M |
| Research & development | 95.30M | 83.29M | 74.14M | 69.15M | 87.07M | 89.47M | 86.48M | 65.04M |
| Operating profit | -43.19M | -57.10M | -70.66M | -33.07M | -117.02M | -103.22M | -132.43M | -95.32M |
| Pretax profit | -43.23M | -65.10M | -143.41M | 319.54M | -120.81M | -362.31M | -250.00M | 49.59M |
| Tax | 2.04M | 4.53M | 6.18M | -2.51M | 2.14M | -641.00K | 2.19M | 14.87M |
| Net profit | -45.26M | -69.63M | -149.59M | 322.05M | -122.95M | -362.95M | -255.59M | 29.88M |
| Basic EPS | 0 | -1 | -1 | 3 | -1 | -3 | -2 | 0 |
| Diluted EPS | -0.41 | -0.61 | -1.27 | 2.55 | -0.96 | -2.79 | -1.94 | 0.19 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 94.54M | 94.84M | 91.25M | 106.28M | 95.54M | 94.58M |
| Gross profit | 32.69M | 36.15M | 29.43M | 32.78M | 34.34M | 34.46M |
| Selling & admin expenses | 49.77M | 30.52M | 33.31M | 48.30M | 31.35M | 35.14M |
| Research & development | 19.68M | 17.36M | 16.03M | 11.97M | 9.64M | 9.97M |
| Operating profit | -36.76M | -11.73M | -19.90M | -27.49M | -6.64M | -10.65M |
| Pretax profit | -35.41M | 116.78M | -19.35M | -12.42M | -2.05M | -11.60M |
| Tax | 671.00K | 11.02M | -2.63M | 5.81M | 1.48M | 354.00K |
| Net profit | -36.99M | 104.44M | -18.05M | -19.51M | -4.58M | -12.86M |
| Basic EPS | 0 | 1 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.28 | 0.57 | -0.14 | -0.15 | -0.03 | -0.09 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 397.47M | 373.17M | 357.52M | 1.03B | 834.25M | 627.82M | 428.83M | 346.71M |
| Cash & ST investments | 110.00M | 133.67M | 75.01M | 789.66M | 568.74M | 331.53M | 171.32M | 95.64M |
| Inventory | 133.16M | 111.11M | 116.67M | 92.89M | 137.83M | 152.19M | 118.53M | 127.50M |
| Total assets | 825.83M | 807.31M | 733.06M | 1.55B | 1.45B | 990.66M | 608.85M | 521.73M |
| Total current liabilities | 164.06M | 162.96M | 175.73M | 178.01M | 151.81M | 147.19M | 139.10M | 120.62M |
| Short-term debt | 654.00K | 12.08M | 11.59M | 8.34M | 9.04M | 11.69M | 11.00M | 17.13M |
| Long-term debt | 25.00M | 45.22M | 19.22M | 446.86M | 449.51M | 319.36M | 212.00M | 86.39M |
| Total liabilities | 240,973,000.00 | 293,416,000.00 | 302,332,000.00 | 706,718,000.00 | 694,909,000.00 | 561,901,000.00 | 430,695,000.00 | 279,177,000.00 |
| Total equity | 584.86M | 513.90M | 430.72M | 842.38M | 751.70M | 428.76M | 178.15M | 242.55M |
| Retained earnings | -722.70M | -793.71M | -943.30M | -621.25M | -743.96M | -1.11B | -1.36B | -1.33B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 401.88M | 390.12M | 361.23M | 346.71M | 340.66M | 365.61M |
| Cash & ST investments | 135.04M | 116.36M | 95.54M | 95.64M | 85.08M | 127.95M |
| Inventory | 120.05M | 132.90M | 132.47M | 127.50M | 127.27M | 121.85M |
| Total assets | 583.36M | 587.84M | 554.55M | 521.73M | 513.12M | 535.24M |
| Total current liabilities | 144.02M | 141.31M | 132.35M | 120.62M | 123.41M | 107.60M |
| Short-term debt | 11.78M | 11.91M | 11.79M | 17.13M | 14.88M | 13.21M |
| Long-term debt | 212.31M | 122.64M | 122.60M | 86.39M | 86.79M | 87.24M |
| Total liabilities | 435,682,000.00 | 344,405,000.00 | 331,257,000.00 | 279,177,000.00 | 278,772,000.00 | 261,681,000.00 |
| Total equity | 147.67M | 243.44M | 223.29M | 242.55M | 234.34M | 273.56M |
| Retained earnings | -1.40B | -1.29B | -1.31B | -1.33B | -1.34B | -1.35B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.80M | 31.58M | -20.12M | 48.15M | -70.02M | -80.70M | -44.89M | -87.83M |
| Depreciation & amortization | 59.29M | 50.40M | 44.60M | 34.62M | 36.03M | 33.41M | 33.31M | 21.51M |
| Free cash flow | -35.90M | 7.60M | -33.76M | 29.36M | -90.93M | -107.88M | -61.01M | -97.77M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 24.70M | -- | -- | 0 | 0 | -14.96M |
| Ending cash balance | 110.92M | 134.62M | 84.71M | 789.97M | 391.98M | 333.11M | 172.88M | 97.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -33.79M | -25.84M | -13.50M | -14.70M | -7.21M | -6.89M |
| Depreciation & amortization | 5.71M | 5.20M | 5.37M | 5.23M | 5.13M | 5.05M |
| Free cash flow | -36.58M | -28.79M | -15.75M | -16.65M | -9.27M | -10.73M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 136.21M | 133.95M | 114.24M | 97.10M | 86.52M | 129.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -7.60 | -12.70 | -31.40 | 50.59 | -15.41 | -61.65 | -84.78 | 14.35 |
| ROA %i | -5.28 | -8.56 | -19.42 | 28.22 | -8.19 | -29.76 | -31.96 | 5.29 |
| ROIC %i | -7.31 | -11.02 | -26.08 | 34.87 | -9.83 | -36.49 | -40.23 | 7.14 |
| 5-year avg ROE %i | -18.08 | -20.83 | -13.66 | -2.34 | -3.30 | -14.11 | -28.53 | -19.38 |
| EBIT margin %i | -6.23 | -9.83 | -25.02 | 52.21 | -21.75 | -73.56 | -56.22 | 14.15 |
| FCF / sales %i | -- | 1.21 | -- | 4.77 | -- | -- | -- | -- |
| Current ratioi | 2.42 | 2.29 | 2.03 | 5.80 | 5.50 | 4.27 | 3.08 | 2.87 |
| Quick ratioi | 1.44 | 1.49 | 1.08 | 5.03 | 4.36 | 2.94 | 1.96 | 1.49 |
| Debt / assetsi | 3.88 | 11.48 | 10.81 | 32.45 | 34.59 | 40.31 | 46.98 | 30.37 |
| LT debt / equityi | 5.43 | 15.44 | 15.71 | 58.68 | 65.51 | 90.83 | 156.12 | 58.80 |
| Interest coveragei | -107.34 | -19.14 | -34.93 | 169.00 | -- | -108.76 | -96.50 | 10.61 |
| Revenue CAGR (3Y) %i | 1.25 | 0.18 | -4.81 | -3.80 | -5.44 | -4.32 | -10.58 | -10.41 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -42.42 | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -99.82 | -46.51 | 7.30 | 14.35 | 32.87 | -21.31 |
| ROA %i | -38.39 | -20.56 | 2.64 | 5.29 | 11.39 | -9.77 |
| ROIC %i | -50.44 | -27.26 | 3.44 | 7.14 | 16.26 | -12.22 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -62.19 | -30.42 | 9.72 | 14.15 | 23.12 | -9.60 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.79 | 2.76 | 2.73 | 2.87 | 2.76 | 3.40 |
| Quick ratioi | 1.66 | 1.51 | 1.39 | 1.49 | 1.39 | 1.93 |
| Debt / assetsi | 47.25 | 31.36 | 32.79 | 30.37 | 28.09 | 26.47 |
| LT debt / equityi | 181.16 | 71.49 | 76.90 | 58.80 | 55.16 | 46.96 |
| Interest coveragei | -110.45 | -50.21 | 9.96 | 10.61 | 13.30 | -4.54 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Healthcare Solutions is the largest reported line at 50.85% of revenue, across 2 reported segments.
- Industrial solutions follows at 49.15%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Healthcare Solutions50.85%
Industrial solutions49.15%
Quote time 2026-10-08 07:56:58 · For reference only, not investment advice and not tailored to your situation.